Last updated on October 2018

A Study to Compare Five Different Treatment Regimens of CNTX-4975 for Participants With Chronic Moderate-to-Severe Osteoarthritis Pain

Brief description of study

This is an open-label, single injection (per knee), 8-week study to evaluate the comfort and ease of use of 5 different treatment regimens, and to evaluate the efficacy and safety of a single intra-articular (IA) injection, in one or both knees, of 1.0 mg of CNTX-4975-05 in subjects with chronic, moderate-to-severe knee OA pain. Procedural pain associated with IA injection of the investigational product, CNTX-4975-05, will be controlled primarily through adjunct controlled joint cooling and secondarily by pre-medication with IA lidocaine.

Clinical Study Identifier: NCT03661996

Contact Investigators or Research Sites near you

Start Over

Study Manager

Metroplex Clinical Research Center
Dallas, TX United States
  Connect »